CTIC - CTi Biopharma Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CTIC is currently covered by 6 analysts with an average price target of $11.23. This is a potential upside of $2.14 (23.54%) from yesterday's end of day stock price of $9.09.

CTi Biopharma Corp's activity chart (see below) currently has 20 price targets and 24 ratings on display. The stock rating distribution of CTIC is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.71% with an average time for these price targets to be met of 228.71 days.

Highest price target for CTIC is $9, Lowest price target is $4, average price target is $11.23.

Most recent stock forecast was given by RENI BENJAMIN from JMP on 24-May-2023. First documented stock forecast 13-Oct-2020.

Currently out of the existing stock ratings of CTIC, 6 are a BUY (50%), 6 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1 years 5 months 20 days ago
(24-May-2023)

4/4 (100%)

$4.25 (89.47%)

124

Hold

$9.1

$0.01 (0.11%)

$13

1 years 5 months 28 days ago
(16-May-2023)

1/2 (50%)

$0.19 (2.13%)

36

Hold

$9.1

$0.01 (0.11%)

$8.1

1 years 5 months 29 days ago
(15-May-2023)

2/2 (100%)

$0.17 (1.90%)

51

Hold

$9

1 years 6 months 2 days ago
(11-May-2023)

5/5 (100%)

$3.88 (75.78%)

190

Hold

$9.1

$0.01 (0.11%)

$8

1 years 6 months 3 days ago
(10-May-2023)

2/2 (100%)

$0.17 (1.90%)

491

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CTIC (CTi Biopharma Corp) average time for price targets to be met?

On average it took 228.71 days on average for the stock forecasts to be realized with a an average price target met ratio 85.71

Which analyst has the current highest performing score on CTIC (CTi Biopharma Corp) with a proven track record?

GIL BLUM

Which analyst has the current lower performing score on CTIC (CTi Biopharma Corp) with a proven track record?

ANDREW BERENS

Which analyst has the most public recommendations on CTIC (CTi Biopharma Corp)?

Gil Blum works at NEEDHAM and has 20 price targets and 22 ratings on CTIC

Which analyst is the currently most bullish on CTIC (CTi Biopharma Corp)?

Andrew Berens with highest potential upside - $0.01

Which analyst is the currently most reserved on CTIC (CTi Biopharma Corp)?

Boris Peaker with lowest potential downside - -$1.09

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?